Cargando…
Sequence homology between human PARP14 and the SARS-CoV-2 ADP ribose 1’-phosphatase
• There is amino acid sequence homology between the ADP-ribose binding sites of human PARP14 and SARS-CoV-2 ADRP. • This homology is even more pronounced in bat species. • The model proposed highlights the potential of the PARP axis to yield druggable targets for the treatment of COVID-19.
Autores principales: | Webb, Thomas E., Saad, Ramy |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Federation of Immunological Societies. Published by Elsevier B.V.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7289111/ https://www.ncbi.nlm.nih.gov/pubmed/32534867 http://dx.doi.org/10.1016/j.imlet.2020.05.008 |
Ejemplares similares
-
Computational Bioprospecting Guggulsterone against ADP Ribose Phosphatase of SARS-CoV-2
por: Kciuk, Mateusz, et al.
Publicado: (2022) -
Crystal structures of SARS-CoV-2 ADP-ribose phosphatase: from the apo form to ligand complexes
por: Michalska, Karolina, et al.
Publicado: (2020) -
Stenoparib, an inhibitor of cellular poly (ADP-ribose) polymerases (PARPs), blocks in vitro replication of SARS-CoV-2 variants
por: Zarn, Katherine E., et al.
Publicado: (2022) -
Poly(ADP-Ribose)Polymerase (PARP) Inhibitors and Radiation Therapy
por: Jannetti, Stephen A., et al.
Publicado: (2020) -
Novel inhibitors to ADP ribose phosphatase of SARS-CoV-2 identified by structure-based high throughput virtual screening and molecular dynamics simulations
por: Patel, Dhrumi C., et al.
Publicado: (2022)